miR-34 regulated genes and pathways as targets for therapeutic intervention

Details for Australian Patent Application No. 2008261951 (hide)

Owner Asuragen, Inc.

Inventors Bader, Andreas G.; Patrawala, Lubna; Johnson, Charles D.; Byrom, Mike; Brown, David

Agent Pizzeys

Pub. Number AU-A-2008261951

PCT Pub. Number WO2008/154333

Priority 60/942,971 08.06.07 US

Filing date 6 June 2008

Wipo publication date 18 December 2008

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/154333 Priority application(s): WO2008/154333

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008261957-Extended release formulation and method of treating adrenergic dysregulation

2008261935-Methods and processes for calling bases in sequence by incorporation methods